Skwyerz in clinical trials?...What could possibly go wrong?
As I was advised the company did not have the resources (legal costs) to launch an uplisting so the decision was made to pursue the long covid Qdot technology! Unfortunately the FDA PMA after the clinical trials is a very lengthy process. Hope we have an FDA consultant in our corner. I am heavily invested so I am encouraged by the shared reply from Amber with IR. $5-$10+
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
